Ayala Pharmaceuticals Inc (AYLA) Stock
AYLA is no longer traded. Ayala Pharmaceuticals Inc was delisted from the Nasdaq in January 2023.
Prices on this page are historical; the last trade was January 18, 2023 at $0.50.
Ayala Pharmaceuticals Inc stock price history
AYLA final trading statistics
- Final close
- $0.50
- Final trading day
- Jan 18, 2023
- Market cap at delisting
- $7.46M
- Shares outstanding
- 14.82M
- Final 52-week range
- $0.36 – $7.31
- Avg. volume (final 3 mo.)
- 66,560
- All-time high (split-adj.)
- $22.00 · Feb 2021
- All-time low (split-adj.)
- $0.38 · Dec 2022
- Return since IPO
- -96.6%
- Beta
- 1.99
- Book value / share
- $0.59
- Price / book
- 0.85
Ayala Pharmaceuticals Inc annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2021 | $3.51M | -$40.3M | -$2.83 |
| FY2020 | $3.71M | -$30.1M | -$3.38 |
| FY2019 | $2.33M | -$17.8M | — |
| FY2018 | $0.00 | -$8.9M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Ayala Pharmaceuticals Inc
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.
Ayala Pharmaceuticals Inc stock FAQ
What happened to Ayala Pharmaceuticals Inc stock?
Ayala Pharmaceuticals Inc stock was delisted from the Nasdaq. Its final close was $0.50 on January 18, 2023.
Is AYLA stock still trading?
No. AYLA was delisted from the Nasdaq in January 2023 and no longer trades on a U.S. exchange.
What was the last price of AYLA stock?
AYLA closed at $0.50 on its final trading day, January 18, 2023, for a market value of about $7.46M.
What were Ayala Pharmaceuticals Inc's revenue and earnings in its last full fiscal year?
Ayala Pharmaceuticals Inc reported revenue of $3.51M and net income of -$40.3M in fiscal 2021, its last full year as a public company.
When did Ayala Pharmaceuticals Inc go public?
Ayala Pharmaceuticals Inc stock began trading on May 8, 2020.